Recent investigations into anti-tumor therapies have revealed that vaccine-induced CD8+ T cells, particularly those expressing granzyme B (GZMB), exhibit significant anti-tumor efficacy in the context of pancreatic cancer treatment [6]. The gene discussed is CD8A; the disease is neoplasm.